Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Clinical Trial for Inactivated Enterovirus Type 71 Vaccine (Human Diploid Cell, KMB-17 Cell) in Chinese Infants

NCT01512706 is registered in ClinicalTrials.gov with Institute of Medical Biology, Chinese Academy of Medical Sciences as lead sponsor.

NCT NCT01512706
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01512706 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Clinical Trial for Inactivated Enterovirus Type 71 Vaccine (Human Diploid Cell, KMB-17 Cell) in Chinese Infants
Lead sponsor
Institute of Medical Biology, Chinese Academy of Medical Sciences
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2011
Completion date
February 29, 2012
Enrollment
660 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

the study focused on the safety of inactivated ev71 vaccine (human diploid cell) against hand, foot and mouth disease in chinese children and infants